This Mendelian randomization study revealed a causal association between genetically predicted cystatin 8 and squamous cell lung carcinoma, while Cystatin D was linked to lung adenocarcinoma after outlier adjustment. Here, CST5 is linked to squamous cell lung carcinoma.